자본 감소했으나…위험가중자산이 더 큰 폭 줄어금감원 "자본비율 양호…손실흡수능력 확충 유도"(금융감독원 제공)김정은 기자 Celltrion's Bold Move: New Drug Listings with Major U.S. PBMs Could Revolutionize Treatment OptionsThe Future of Blood Glucose Management in 2026: What to Expect from the Integration of GCFiT and CGM
